PHARMACEUTICAL RESEARCH, vol.21, no.2, pp.261-270, 2004 (SCI-Expanded)
Purpose. The objective of this study was to evaluate the pharmacokinetics of paclitaxel in a novel self-microemulsifying drug delivery system (SMEDDS) for improved oral administration with or without P-glycoprotein (P-gp) inhibitors.